Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Factor VIII products and inhibitors in severe hemophilia A.

van den Berg HM, Gouw SC, van der Bom JG.

N Engl J Med. 2013 Apr 11;368(15):1457. doi: 10.1056/NEJMc1301995. No abstract available.

2.

Factor VIII products and inhibitors in severe hemophilia A.

Iorio A, Skinner MW, Makris M.

N Engl J Med. 2013 Apr 11;368(15):1456. doi: 10.1056/NEJMc1301995#SA1. No abstract available.

PMID:
23574132
3.

Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study.

Gouw SC, van der Bom JG, Auerswald G, Ettinghausen CE, Tedgård U, van den Berg HM.

Blood. 2007 Jun 1;109(11):4693-7. Epub 2007 Jan 11.

4.

Inhibitor development in a multitransfused patient with severe haemophilia A.

van den Berg HM, Roosendaal G, Voorberg J, Mauser-Bunschoten EP.

Thromb Haemost. 1999 Jul;82(1):151-2. No abstract available.

PMID:
10456472
5.

A sudden increase in factor VIII inhibitor development in multitransfused hemophilia A patients in The Netherlands. Dutch Hemophilia Study Group.

Rosendaal FR, Nieuwenhuis HK, van den Berg HM, Heijboer H, Mauser-Bunschoten EP, van der Meer J, Smit C, Strengers PF, Briët E.

Blood. 1993 Apr 15;81(8):2180-6.

7.

Neoantigens and antibodies to factor VIII.

Prowse CV, MacGregor IR.

Blood Rev. 1998 Jun;12(2):99-105. Review.

PMID:
9661798
8.

Prevalence of factor VIII inhibitors in patients with hemophilia A in Brazil.

Rieger A, Roisenberg I.

Thromb Haemost. 1999 Mar;81(3):475-6. No abstract available.

PMID:
10102489
9.

Factor VIII inhibitors in hemophilia.

Mariani G.

Bilt Hematol Transfuz. 1979;7(1):3-41. English, Croatian. No abstract available.

PMID:
121880
10.

T lymphocyte proliferative responses induced by recombinant factor VIII in hemophilia A patients with inhibitors.

Singer ST, Addiego JE Jr, Reason DC, Lucas AH.

Thromb Haemost. 1996 Jul;76(1):17-22.

PMID:
8819245
11.

[Treatment of hemorrhage in a patient with severe hemophilia A and factor VIII antibodies].

Gassmann AE, Kerkhofs H, Leeksma CH.

Schweiz Med Wochenschr. 1970 Oct 10;100(41):1734-6. German. No abstract available.

PMID:
5480542
12.

[Inhibitor hemophilia A--diagnostic and therapeutic significance of controlled substitutions with factor VIII].

Weippert M, Anders O, Schmidt M, Roewer J.

Beitr Infusionsther. 1990;26:174-8. German.

PMID:
1703823
13.

Evaluation of a novel ELISA screening test for detection of factor VIII inhibitory antibodies in haemophiliacs.

Martin PG, Sukhu K, Chambers E, Giangrande PL.

Clin Lab Haematol. 1999 Apr;21(2):125-8.

PMID:
10342072
14.

[Importance of corticoids in inhibitor suppression in hemophilia A, in addition to continuing treatment with factor VIII concentrate].

Aznar JA, Jorquera JI, Marty ML.

Sangre (Barc). 1983;28(3):265-79. Spanish. No abstract available.

PMID:
6414098
15.

Panel discussion on the treatment of patients with factor VIII inhibitors.

Lusher JM, Eyster ME, Hilgartner MW, Kasper CK, Mannucci PM, Nilsson IM, Penner JA, Roberts HR.

Prog Clin Biol Res. 1984;150:323-35. No abstract available.

PMID:
6431437
16.

Treatment of anti-factor VIII antibodies.

Blatt PM, White GC 2nd, McMillan CW, Roberts HR.

Thromb Haemost. 1977 Aug 31;38(2):514-23.

PMID:
579493
17.

Inhibitors of factor VIII in hemophilia.

Lacroix-Desmazes S, Dimitrov JD, Repesse Y.

N Engl J Med. 2009 Jul 16;361(3):308; author reply 310. doi: 10.1056/NEJMc091067. No abstract available.

18.

Purity of factor VIII product and incidence of inhibitors in previously untreated patients with haemophilia A.

Mauser-Bunschoten EP, van der Bom JG, Bongers M, Twijnstra M, Roosendaal G, Fischer K, van den Berg HM.

Haemophilia. 2001 Jul;7(4):364-8.

PMID:
11442640
19.

Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A.

Goudemand J, Rothschild C, Demiguel V, Vinciguerrat C, Lambert T, Chambost H, Borel-Derlon A, Claeyssens S, Laurian Y, Calvez T; FVIII-LFB and Recombinant FVIII study groups.

Blood. 2006 Jan 1;107(1):46-51. Epub 2005 Sep 15.

20.

Inhibitors of factor VIII in hemophilia.

Eckhardt CL, Kamphuisen PW, Fijnvandraat K.

N Engl J Med. 2009 Jul 16;361(3):309; author reply 310. No abstract available.

PMID:
19610163

Supplemental Content

Support Center